IPS Genomix

About IPS Genomix

IPS Genomix stands for innovation that benefits to the community. Specialized in the latest prognostic, predictive and personalized medicine, IPS Genomix gives treating physicians access to important and clinically relevant genomic information further to testing human specimens (tissue, blood, saliva, buccal swab…) in the European or US partnering laboratories accredited and specialized in this field.
YEAR FOUNDED:
2013
LEADERSHIP:
CEO: Ahmed Yacout
COO: Rima Helou
CPO: Sylvana L Nader
CFO: Olivier Gaudin
JOBS:
Please click here for IPS Genomix job opportunities.